Population‐based patient‐reported quality of life outcomes following low‐dose‐rate versus high‐dose‐rate brachytherapy monotherapy for low‐intermediate risk prostate cancer

GEC-ESTRO ACROP prostate brachytherapy guidelines

(2022) Ann Henry et al.   RADIOTHERAPY AND ONCOLOGY

Comparison of urinary and sexual patient-reported outcomes between open radical prostatectomy and robot-assisted radical prostatectomy: a propensity score matched, population-based study in Victoria

(2022) Michael Rechtman et al.   BMC Urology

Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer

(2022) Michael Harvey et al.   BJU INTERNATIONAL

Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia

(2022) Wee Loon Ong et al.   Clinical and Translational Radiation Oncology

Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer

(2021) Jonathan J. Paly et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial

(2021) Mark Corkum et al.   RADIOTHERAPY AND ONCOLOGY

PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study

(2021) Thomas Reynaud et al.   Brachytherapy

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy

(2020) Gerard Morton et al.   RADIOTHERAPY AND ONCOLOGY

Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: a national population-based study

(2020) Matthew G. Parry et al.   RADIOTHERAPY AND ONCOLOGY

Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study

(2020) Matthew G. Parry et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer

(2020) Emile Gogineni et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial

(2019) Steven Tissaverasinghe et al.   Brachytherapy

A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer

(2019) Matthew J. Roberts et al.   BJU INTERNATIONAL

Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy

(2017) Wee Loon Ong et al.   Journal of Medical Imaging and Radiation Oncology

The evolution of brachytherapy for prostate cancer

(2017) Nicholas G. Zaorsky et al.   Nature Reviews Urology

Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer

(2017) Peter Hoskin et al.   RADIOTHERAPY AND ONCOLOGY

Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy

(2016) Jonathan D. Tward et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer

(2015) Wee Loon Ong et al.   Journal of Sexual Medicine

Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form

(2015) Ted A. Skolarus et al.   UROLOGY

The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer

(2012) Sue M. Evans et al.   BJU INTERNATIONAL

High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial

(2011) Maroie Barkati et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors

(2010) Konrad M. Szymanski et al.   UROLOGY